Hot Topic Discussion: Individual Risk Assessment: What You Need to Know as the US Prepares for FDA's Decision (23EL-803) – Free for everyone!

Please note: AABB reserves the right to make updates to this program.

• Program Description

  Join us for a conversation about individual risk assessment to establish donor eligibility, and its implications for the blood supply and the blood community in the US. Panelists will include experts who share the Canadian implementation experience and the anticipated regulatory path ahead for the US. Although details of the FDA’s future decision are not yet available (as of the time of the live program), experts will explain the regulatory process and provide insight on changes that would ultimately impact the timing of each step in this historic transition.

  Agenda & Faculty

  • Introduction/Overview: Sharon Carayiannis, AABB
  • Canadian experience: Mindy Goldman, Canadian Blood Services
  • Keys to success in Canada, including engagement: Terrie Foster, Canadian Blood Services
  • Regulatory landscape, dependencies for key steps: Sharon Carayiannis, AABB

  Learning Objectives

  After participating in this educational activity, participants should be able to:

  • Identity the donor eligibility criteria and key outcomes in Canada's implementation experience.
  • Discuss the importance of community engagement and staff/volunteer training in the Canadian experience.
  • Describe key steps in the US regulatory process that must occur before implementation is permitted.

  Continuing Education Credit

  Continuing education credit will not be offered for this program.

  Register